Kolexia
Lacombe Karine
Santé publique
Hôpital Saint-Antoine
Paris, France
727 Activités
24.5 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Infections à VIH Hépatite C Co-infection COVID-19 Hépatite B Hépatite C chronique Maladies transmissibles Cirrhose du foie

Industries

MSD
59 collaboration(s)
Dernière en 2023
Gilead
25 collaboration(s)
Dernière en 2023
Janssen
17 collaboration(s)
Dernière en 2022
KEPHREN PUBLISHING
17 collaboration(s)
Dernière en 2023

Dernières activités

What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?
Journal of the International AIDS Society   07 mars 2024
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of infection   16 février 2024
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.
Hepatology (Baltimore, Md.)   22 janvier 2024
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies.
The lancet. HIV   12 janvier 2024
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019.
The International journal on drug policy   06 janvier 2024
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC).
International journal of epidemiology   08 décembre 2023
HIV viremias among patients who discontinued Cabotegravir (CAB)/Rilpivirine (RPV) Long acting (LA) intramuscular (IM) in real-life setting
HIV medicine Congress 2023   01 décembre 2023
ANRS 177 DUETTO randomized, open-label and multicentric trial evaluating the non-inferiority of maintenance antiretroviral dual therapy taken 4 consecutive days per week versus dual therapy 7/7 days per week
HIV medicine Congress 2023   01 décembre 2023
High proportion of post-migration HIV acquisition in immigrant men who have sex with men receiving HIV care in France, and association with social disadvantage and sexual behaviours: Results of the ANRS-MIE GANYMEDE study
HIV medicine Congress 2023   01 décembre 2023
HBcAb positivity is a risk factor for failure to achieve complete virologic suppression of HIV-RNA after antiretroviral switch to 3TC+DTG
HIV medicine Congress 2023   01 décembre 2023